日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

3-磷酸肌醇依赖性激酶 1 驱动对奥希替尼的获得性耐药性

Ismail M Meraz, Mourad Majidi, Bingliang Fang, Feng Meng, Lihui Gao, RuPing Shao, Renduo Song, Feng Li, Yonathan Lissanu, Huiqin Chen, Min Jin Ha, Qi Wang, Jing Wang, Elizabeth Shpall, Sung Yun Jung, Franziska Haderk, Philippe Gui, Jonathan Wesley Riess, Victor Olivas, Trever G Bivona, Jack A Roth

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model

TUSC2 免疫基因增强人源化小鼠模型中化学免疫联合治疗 KRAS/LKB1 突变型 NSCLC 的疗效

Ismail M Meraz, Mourad Majidi, RuPing Shao, Feng Meng, Min Jin Ha, Elizabeth Shpall, Jack A Roth

Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells

PI4K2A/PKR 溶酶体网络的治疗靶向性对于清除错误折叠的蛋白质和癌细胞存活至关重要

Apar Pataer, Bulent Ozpolat, RuPing Shao, Neil R Cashman, Steven S Plotkin, Charles E Samuel, Steven H Lin, Nashwa N Kabil, Jing Wang, Mourad Majidi, Bingliang Fang, Jack A Roth, Ara A Vaporciyan, Ignacio I Wistuba, Mien-Chie Hung, Stephen G Swisher

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy

主要病理反应和 RAD51 可预测接受新辅助化疗的肺癌患者的生存率

Apar Pataer, Ruping Shao, Arlene M Correa, Carmen Behrens, Jack A Roth, Ara A Vaporciyan, Ignacio I Wistuba, Stephen G Swisher

Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics

用于递送合成 RNAi 疗法的阳离子液晶纳米粒子

Emanuela Gentile, Taro Oba, Jing Lin, Ruping Shao, Feng Meng, Xiaobo Cao, Heather Y Lin, Majidi Mourad, Apar Pataer, Veerabhadran Baladandayuthapani, Dong Cai, Jack A Roth, Lin Ji

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

TUSC2(FUS1)-厄洛替尼诱导表皮生长因子受体 (EGFR) 野生型非小细胞肺癌 (NSCLC) 的脆弱性,而重新利用的药物金诺芬可靶向该药物

Cao Xiaobo, Mourad Majidi, Meng Feng, Ruping Shao, Jing Wang, Yang Zhao, Veerabhadran Baladandayuthapani, Juhee Song, Bingliang Fang, Lin Ji, Reza Mehran, Jack A Roth

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

金诺芬介导对非小细胞肺癌细胞中 PI3K/AKT/mTOR 轴的抑制及其抗癌活性

Hongyu Li, Jing Hu, Shuhong Wu, Li Wang, Xiaobo Cao, Xiaoshan Zhang, Bingbing Dai, Mengru Cao, Ruping Shao, Ran Zhang, Mourad Majidi, Lin Ji, John V Heymach, Michael Wang, Shiyang Pan, John Minna, Reza J Mehran, Stephen G Swisher, Jack A Roth, Bingliang Fang

RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer

RNA 依赖性蛋白激酶 (PKR) 消耗营养物质,诱导肺癌中 AMP 活化激酶的磷酸化

Chengcheng Guo, Chuncheng Hao, RuPing Shao, Bingliang Fang, Arlene M Correa, Wayne L Hofstetter, Jack A Roth, Carmen Behrens, Neda Kalhor, Ignacio I Wistuba, Stephen G Swisher, Apar Pataer

Near-infrared light triggers release of Paclitaxel from biodegradable microspheres: photothermal effect and enhanced antitumor activity

近红外光触发可生物降解微球释放紫杉醇:光热效应和增强的抗肿瘤活性

Jian You, Ruping Shao, Xin Wei, Sanjay Gupta, Chun Li